Overview

Transcranial Magnetic Stimulation (TMS) for Patients With Treatment Resistant Auditory Verbal Hallucination

Status:
Unknown status
Trial end date:
2019-02-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment resistant auditory verbal hallucination
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Dr Cipto Mangunkusumo General Hospital
Criteria
Inclusion Criteria:

1. Met the criteria of all types of schizophrenia or schizoaffective based on structured
clinical interview instruments for the DSM-IV axis I disorders (SCID-I)

2. Patients had entered the stabilization phase with 2 to 3 months of antipsychotic
treatment and no drug changes within the last 2 (two) months

3. Elementary school graduated (minimum)

Exclusion Criteria:

1. Patients with a history of stroke, heart failure, head injury, infection or brain
tumor, epilepsy, alcohol and opiate abuse, amphetamines obtained from anamnesis,
physical examination and patient medical records

2. Patients with neurological focal deficits such as hemiparesis and cranial nerve
paresis

3. Patients with severe cognitive deficits (MMSE scores <25 in the first and second
graders of Senior Secondary School and <21 in Primary School Graduates)

4. Patients with severe hearing loss were assessed with a 5-word auditory test

5. Patients with mental retardation, assessed using the Wechsler Test of Adult Reading
(WTAR) test and data from medical records.